Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-15

Clinical Trial Update: Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating different numbers of injections at the same dose of Botulinum toxin A for overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED